Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

May 18, 2022

Good TAVI Results Seen Bicuspid Aortic Stenosis TVT Registry.PNG

News Conference News EuroPCR 2021

Good TAVI Results Seen in Bicuspid Aortic Stenosis: TVT Registry

May 20, 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

May 19, 2021

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

News Conference News EuroPCR 2019

MR Reduction Linked to Lower HF Hospitalizations and Deaths, Regardless of Intervention: COAPT

May 21, 2019

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

May 23, 2018

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

May 17, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

May 20, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.